All Articles

The NALIRICC study did not meet overall survival or progression-free survival end points, with nanoliposomal irinotecan plus 5-fluorouracil falling short in patients with metastatic biliary tract cancer.

Preliminary quality-of-life data suggest a potentially positive impact of L-folinic acid plus oxaliplatin plus 5-fluorouracil when used in conjunction with active symptom control.

Real-world evidence supports a role for liquid biopsy in identifying molecular alterations and offering personalized treatment options, with IDH1 identified in a patient with cholangiocarcinoma.

Navigation programs continue to flourish in the oncology setting and expand into the chronic disease space. As navigation continues to grow and evolve, the Academy of Oncology Nurse & Patient Navigators (AONN+) is committed to providing professional development opportunities.

It was September 2019. My colleagues and I had been immersed in articles and presentations regarding the “financial toxicity” that was affecting a large cohort of our cancer patients.

Although cancer diagnoses and deaths have been declining in the United States, COVID-19 has impacted cancer screening rates, and the concern is this will lead to increases in late-stage diagnoses and increases in cancer mortality.

Identify barriers for referral to a new interprofessional cancer survivorship clinic.